Copyright
©The Author(s) 2025.
World J Radiol. Jun 28, 2025; 17(6): 105962
Published online Jun 28, 2025. doi: 10.4329/wjr.v17.i6.105962
Published online Jun 28, 2025. doi: 10.4329/wjr.v17.i6.105962
Table 1 Postoperative characteristics of the acute kidney injury group, n (%)
Postoperative characteristics | |
AKI | 53 (43.80) |
Stage 1 | 30 (56.60) |
Stage 2 | 18 (33.96) |
Stage 3 | 5 (9.43) |
PODs of AKI diagnosis | |
1 | 49 (92.45) |
2 | 4 (7.55) |
PODs when AKI resolved | |
2 | 4 (9.30) |
3 | 6 (13.95) |
4 | 19 (44.19) |
5 | 6 (13.95) |
6 | 8 (18.60) |
AKI not resolved | 10 (18.87) |
Stage 1 | 2 (20) |
Stage 2 | 3 (30) |
Stage 3 | 5 (50) |
Table 2 Comparison of perioperative variables between the acute kidney injury and non-acute-kidney-injury groups, mean ± SD/n (%)
AKI | Non-AKI | P value | |
Age, years | 50.49 ± 8.51 | 44.94 ± 9.04 | 0.73 |
Female sex | 8 (15.09) | 13 (19.12) | 0.56 |
BMI, kg/m2 | 26.02 ± 4.17 | 22.96 ± 3.46 | < 0.01 |
Comorbidities | |||
Diabetes mellitus | 7 (13.21) | 4 (5.88) | 0.17 |
Hypertension | 6 (8.82) | 5 (9.43) | 0.91 |
Etiology of liver failure | 0.77 | ||
Malignant neoplastic disease | 23 (43.40) | 29 (42.60) | |
Virus (HBV) | 24 (45.30) | 23 (33.80) | |
Ethanol | 4 (7.50) | 7 (10.30) | |
Cholestatic liver disease | 1 (1.9) | 4 (5.90) | |
Autoimmune disease | 1 (1.9) | 5 (7.40) | |
MELD score | 14.61 ± 5.94 | 12.94 ± 6.45 | 0.15 |
Creatinine, μmol/L | 78.47 ± 19.49 | 74.25 ± 19.26 | 0.24 |
Urea nitrogen, mmol/L | 5.21± 2.00 | 5.14± 1.84 | 0.85 |
Cys C, mg/L | 1.32 ± 0.42 | 1.14 ± 0.33 | 0.02 |
eGFR, mL/minute/1.73 m2 | 81.84 ± 4.18 | 88.63 ± 30.58 | 0.19 |
Albumin, g/L | 33.27 ± 5.10 | 33.09 ± 7.32 | 0.88 |
IVC cross clamp | 0.86 | ||
Partial (n = 2) | 1 (1.89) | 1 (1.47) | |
Complete (n = 119) | 52 (98.11) | 67 (98.53) | |
Mean intraoperative blood products transfused | |||
Erythrocytes | 4.5 (2-10) | 6 (4-8.5) | 0.72 |
Platelets | 0 (0-1) | 0 (0-0) | < 0.01 |
Surgical duration, hours | 8.69 ± 1.66 | 8.03 ± 1.54 | 0.03 |
Anhepatic duration, minutes | 41.26 ± 12.94 | 38.13 ± 10.23 | 0.14 |
HRI on POD 1 | 1.08 ± 0.21 | 1.40 ± 0.35 | < 0.01 |
RRI on POD 1 | 0.69 ± 0.04 | 0.63 ± 0.05 | < 0.01 |
Table 3 Paired comparisons
n | P value | ||
HRId vs HRIm | 1.13 vs 1.38 | 43 | < 0.01 |
HRIr-1 vs HRIm | 1.28 vs 1.38 | 43 | 0.04 |
HRIr vs HRIm | 1.37 vs 1.38 | 43 | 0.92 |
HRId vs HRIr-1 | 1.13 vs 1.28 | 43 | < 0.01 |
HRId vs HRIr | 1.13 vs 1.37 | 43 | < 0.01 |
HRIr-1 vs HRIr | 1.28 vs 1.37 | 43 | < 0.01 |
RRId vs RRIm | 0.69 vs 0.61 | 43 | < 0.01 |
RRIr-1 vs RRIm | 0.63 vs 0.61 | 43 | < 0.01 |
RRIr vs RRIm | 0.61 vs 0.61 | 43 | 0.62 |
RRId vs RRIr-1 | 0.69 vs 0.63 | 43 | < 0.01 |
RRId vs RRIr | 0.69 vs 0.61 | 43 | < 0.01 |
RRIr-1 vs RRIr | 0.63 vs 0.61 | 43 | 0.001 |
- Citation: Zhang D, Sun J, Xu CS, Yang ZZ, Wu XD, Zhao K, Cai JZ, Wang JH. Role of sonographic hepatorenal index and renal resistive index in monitoring of acute kidney injury after liver transplantation. World J Radiol 2025; 17(6): 105962
- URL: https://www.wjgnet.com/1949-8470/full/v17/i6/105962.htm
- DOI: https://dx.doi.org/10.4329/wjr.v17.i6.105962